Sensorineural hearing loss following imatinib (Gleevec) administration

Otolaryngol Head Neck Surg. 2012 Feb;146(2):335-7. doi: 10.1177/0194599811415008. Epub 2011 Jul 13.
No abstract available

Keywords: hearing loss; imatinib; nephrogenic systemic fibrosis; ototoxicity.

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Benzamides / adverse effects*
  • Female
  • Hearing Loss, Sensorineural / chemically induced*
  • Humans
  • Imatinib Mesylate
  • Middle Aged
  • Piperazines / adverse effects*
  • Protein Kinase Inhibitors / adverse effects*
  • Pyrimidines / adverse effects*

Substances

  • Benzamides
  • Piperazines
  • Protein Kinase Inhibitors
  • Pyrimidines
  • Imatinib Mesylate